Innovation Pharmaceuticals Inc (IPIX)

[MackG]

CMC, thanks for helping to keep in focus the tremendous investment opportunity with IPIX at this juncture. I especially liked this part of your post: "One thing's for sure, the antiviral sector is Brilacidin's most lucrative area ($67B) and IPIX is in collaboration with an agency of the U.S. government (NIAID) that is extremely interested in investigating "B" ,as an antiviral, for all that it can do. AT NO CHARGE TO IPIX.
NIAID, operating in its own interest with Brilacidin, could be a very, very, financially rewarding collaboration for IPIX. This is what NIAID's drug development track record suggest.